Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Radiotherapy Side Effect Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

4 recruiting trials for Radiotherapy Side Effect. Eligibility criteria explained in plain English.

TrialFinderData lists 4 Radiotherapy Side Effect clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1), Umeå University (1), Jiangxi Provincial Cancer Hospital (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is MR-linac (device, 1 trial), followed by Moderate hypo-fractionation, Ultra-hypo-fractionation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
4
Total Trials
4
Recruiting Now
1
Phase 3 Trials
4
Sponsors

Track Radiotherapy Side Effect trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05183074

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

1. To investigate the tolerability of MR-linac based stereotactic ablative radiotherapy (MRL-SBRT)for patients with localized prostate cancer 2. To assess the acute and late...

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 501 location
RECRUITINGNCT04612907

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer

de Novo metastatic prostate cancer with limited metastatic spread benefits from local radiotherapy to the prostate. Two different fractionation schedules will be tested.

Sponsor: Umeå UniversityEnrolling: 4201 location
RECRUITINGPhase 3NCT06752239

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

This study is a multicenter, non-inferiority, open-label, randomized controlled Phase III clinical trial. It aims to compare the efficacy of modified delineation radiotherapy...

Sponsor: Jiangxi Provincial Cancer HospitalEnrolling: 4741 location
RECRUITINGNCT04986293

CPAP or BiPAP for Motion Mitigation During Radiotherapy

When using highly conformal radiotherapy techniques, such as proton therapy, a controlled breathing pattern and a minimal breathing amplitude could greatly benefit the treatment...

Sponsor: University Medical Center GroningenEnrolling: 311 location

Frequently Asked Questions

There are currently 4 clinical trials for Radiotherapy Side Effect, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Radiotherapy Side Effect, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Radiotherapy Side Effect, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.